Market Cap 26.65B
Revenue (ttm) 4.66B
Net Income (ttm) 836.30M
EPS (ttm) N/A
PE Ratio 31.10
Forward PE 28.14
Profit Margin 17.94%
Debt to Equity Ratio 0.42
Volume 3,831,900
Avg Vol 6,042,540
Day's Range N/A - N/A
Shares Out 385.87M
Stochastic %K 16%
Beta 1.45
Analysts Strong Sell
Price Target $84.00

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with predi...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
AXLFI_HQ
AXLFI_HQ Jun. 23 at 11:28 PM
$DXCM FDA regulatory approvals are expanding for healthcare innovations including novel antibiotics, immunotherapies, and precision diagnostics, creating new market opportunities and growth drivers for medical device and pharmaceutical companies. Learn more: https://axlfi.com/themes/357
0 · Reply
Chrissytina
Chrissytina Jun. 23 at 3:40 PM
$DXCM Just another buy signal at to $86 so 🤷🏼‍♀️
0 · Reply
Mobagri
Mobagri Jun. 23 at 12:58 PM
$DXCM https://ca.investing.com/news/stock-market-news/deutsche-bank-initiates-dexcom-stock-with-buy-rating-on-cgm-growth-93CH-4703240
0 · Reply
anvesti
anvesti Jun. 22 at 7:43 PM
Anvesti opened a long position $DXCM · Entry $68.82 Model: ml_model_v2 · Score: 82.8
0 · Reply
Chrissytina
Chrissytina Jun. 22 at 3:48 PM
$DXCM All upgrades last week from $88 to as high as $95 so what’s the problem…??? Does anyone else feel like👇🏻😤
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 3:11 PM
$DXCM Share Price: $69.54 Contract Selected: Jul 17, 2026 $70 Calls Buy Zone: $2.51 – $3.10 Target Zone: $4.36 – $5.33 Potential Upside: 64% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
AdamBrennan2
AdamBrennan2 Jun. 18 at 11:02 AM
$TNDM is basically a razor/razorblade business hiding inside a medical device company the pump is the razor, insulin cartridges and infusion sets come back every 3-7 days, per user, recurring revenue Their supplier are $DXCM and $ABT for the CGM sensors that make the closed-loop system work. without these sensors, no automation 30% of revenue already comes from 25+ countries internationally, and they're now pushing the addressable market into Type 2 diabetes 500k users today. Type 2 is a completely different scale
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 16 at 11:01 PM
$DXCM Small-cap pharmaceutical and medical device companies are achieving revenue acceleration and profitability improvement through FDA regulatory approvals, product innovation, and commercial partnerships. Learn more: https://axlfi.com/themes/357
0 · Reply
Invest2live
Invest2live Jun. 16 at 5:33 PM
$CSCO 153% already; congrats 🎊 🌷🔆 Checkout $FIS and $DXCM. Excellent value.
0 · Reply
prismmarketview
prismmarketview Jun. 16 at 12:59 PM
$DXCM FDA clears Stelo as the first OTC CGM for kids 2+ (non‑insulin users). This pushes CGMs further into the mass‑market consumer + pediatric segment, beyond core insulin‑using patients. #DXCM #CGM #diabetes #medtech #growth https://prismmarketview.com/fda-approves-first-otc-glucose-monitor-for-kids-gets-green-light/
0 · Reply
Latest News on DXCM
DexCom initiated with a Buy at Deutsche Bank

2026-06-23T16:59:55.000Z - 1 day ago

DexCom initiated with a Buy at Deutsche Bank


DexCom initiated with a Buy at Deutsche Bank

2026-06-23T13:19:58.000Z - 1 day ago

DexCom initiated with a Buy at Deutsche Bank


Dexcom Further Advances Vision of Glucose Biosensing for All

Jun 23, 2026, 9:00 AM EDT - 1 day ago

Dexcom Further Advances Vision of Glucose Biosensing for All


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 7 days ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


DexCom price target raised to $88 from $75 at Piper Sandler

2026-06-15T10:42:11.000Z - 9 days ago

DexCom price target raised to $88 from $75 at Piper Sandler


FDA clears first over-the-counter glucose monitor for children

Jun 12, 2026, 4:15 PM EDT - 12 days ago

FDA clears first over-the-counter glucose monitor for children


DexCom price target raised to $95 from $75 at TD Cowen

2026-06-10T12:28:14.000Z - 14 days ago

DexCom price target raised to $95 from $75 at TD Cowen


DexCom price target raised to $85 from $75 at Mizuho

2026-06-09T11:10:24.000Z - 15 days ago

DexCom price target raised to $85 from $75 at Mizuho


DexCom price target raised to $91 from $81 at Raymond James

2026-06-08T19:20:09.000Z - 16 days ago

DexCom price target raised to $91 from $81 at Raymond James


DexCom announces results from CONNECT trial of Dexcom G7

2026-06-07T22:00:07.000Z - 17 days ago

DexCom announces results from CONNECT trial of Dexcom G7


DexCom price target raised to $90 from $85 at Stifel

2026-06-05T11:09:50.000Z - 19 days ago

DexCom price target raised to $90 from $85 at Stifel


DexCom price target raised to $84 from $79 at Citi

2026-05-28T12:20:33.000Z - 27 days ago

DexCom price target raised to $84 from $79 at Citi


DexCom identifies theft of scrapped Dexcom G7 sensors

2026-05-26T16:46:26.000Z - 4 weeks ago

DexCom identifies theft of scrapped Dexcom G7 sensors


Dexcom warns patients as stolen glucose sensors hit the market

May 26, 2026, 10:47 AM EDT - 4 weeks ago

Dexcom warns patients as stolen glucose sensors hit the market


DexCom announces Dexcom Flex in Germany

2026-05-18T11:48:09.000Z - 5 weeks ago

DexCom announces Dexcom Flex in Germany


DexCom price target lowered to $80 from $100 at BofA

2026-05-18T11:28:09.000Z - 5 weeks ago

DexCom price target lowered to $80 from $100 at BofA


DexCom price target lowered to $82 from $100 at Canaccord

2026-05-18T11:10:49.000Z - 5 weeks ago

DexCom price target lowered to $82 from $100 at Canaccord


DexCom price target lowered to $64 from $67 at Barclays

2026-05-18T09:46:16.000Z - 5 weeks ago

DexCom price target lowered to $64 from $67 at Barclays


DexCom Transcript: Investor Day 2026

May 14, 2026, 4:15 PM EDT - 5 weeks ago

DexCom Transcript: Investor Day 2026


DexCom Slides: FY 2026

May 14, 2026, 4:15 PM EDT - 5 weeks ago

DexCom Slides: FY 2026


Dexcom to Host Investor Day on May 14, 2026

May 5, 2026, 8:30 AM EDT - 7 weeks ago

Dexcom to Host Investor Day on May 14, 2026


DexCom Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 7 weeks ago

DexCom Earnings Call Transcript: Q1 2026


DexCom Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 7 weeks ago

DexCom Earnings release: Q1 2026


DexCom Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 7 weeks ago

DexCom Slides: Q1 2026


DexCom Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 7 weeks ago

DexCom Quarterly report: Q1 2026


Dexcom Reports First Quarter 2026 Financial Results

Apr 30, 2026, 4:02 PM EDT - 7 weeks ago

Dexcom Reports First Quarter 2026 Financial Results


DexCom Slides: Investor presentation

Apr 30, 2026, 7:00 AM EDT - 7 weeks ago

DexCom Slides: Investor presentation


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 2 months ago

DexCom Proxy statement: Proxy filing


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 2 months ago

DexCom Proxy statement: Proxy filing


Dexcom Appoints Rick Osterloh to Board of Directors

Feb 26, 2026, 4:15 PM EST - 4 months ago

Dexcom Appoints Rick Osterloh to Board of Directors


Dexcom Announces Upcoming Conference Presentation

Feb 25, 2026, 8:30 AM EST - 4 months ago

Dexcom Announces Upcoming Conference Presentation


The Big 3: VZ, DXCM, AMAT

Feb 19, 2026, 1:00 PM EST - 4 months ago

The Big 3: VZ, DXCM, AMAT

AMAT VZ


DexCom Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

DexCom Earnings Call Transcript: Q4 2025


DexCom Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

DexCom Annual report: Q4 2025


DexCom Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

DexCom Earnings release: Q4 2025


DexCom Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

DexCom Slides: Q4 2025


DexCom Slides: Investor presentation

Feb 12, 2026, 7:00 AM EST - 4 months ago

DexCom Slides: Investor presentation


Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 5 months ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach


DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 5 months ago

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference


DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 5 months ago

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference


AXLFI_HQ
AXLFI_HQ Jun. 23 at 11:28 PM
$DXCM FDA regulatory approvals are expanding for healthcare innovations including novel antibiotics, immunotherapies, and precision diagnostics, creating new market opportunities and growth drivers for medical device and pharmaceutical companies. Learn more: https://axlfi.com/themes/357
0 · Reply
Chrissytina
Chrissytina Jun. 23 at 3:40 PM
$DXCM Just another buy signal at to $86 so 🤷🏼‍♀️
0 · Reply
Mobagri
Mobagri Jun. 23 at 12:58 PM
$DXCM https://ca.investing.com/news/stock-market-news/deutsche-bank-initiates-dexcom-stock-with-buy-rating-on-cgm-growth-93CH-4703240
0 · Reply
anvesti
anvesti Jun. 22 at 7:43 PM
Anvesti opened a long position $DXCM · Entry $68.82 Model: ml_model_v2 · Score: 82.8
0 · Reply
Chrissytina
Chrissytina Jun. 22 at 3:48 PM
$DXCM All upgrades last week from $88 to as high as $95 so what’s the problem…??? Does anyone else feel like👇🏻😤
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 3:11 PM
$DXCM Share Price: $69.54 Contract Selected: Jul 17, 2026 $70 Calls Buy Zone: $2.51 – $3.10 Target Zone: $4.36 – $5.33 Potential Upside: 64% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
AdamBrennan2
AdamBrennan2 Jun. 18 at 11:02 AM
$TNDM is basically a razor/razorblade business hiding inside a medical device company the pump is the razor, insulin cartridges and infusion sets come back every 3-7 days, per user, recurring revenue Their supplier are $DXCM and $ABT for the CGM sensors that make the closed-loop system work. without these sensors, no automation 30% of revenue already comes from 25+ countries internationally, and they're now pushing the addressable market into Type 2 diabetes 500k users today. Type 2 is a completely different scale
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 16 at 11:01 PM
$DXCM Small-cap pharmaceutical and medical device companies are achieving revenue acceleration and profitability improvement through FDA regulatory approvals, product innovation, and commercial partnerships. Learn more: https://axlfi.com/themes/357
0 · Reply
Invest2live
Invest2live Jun. 16 at 5:33 PM
$CSCO 153% already; congrats 🎊 🌷🔆 Checkout $FIS and $DXCM. Excellent value.
0 · Reply
prismmarketview
prismmarketview Jun. 16 at 12:59 PM
$DXCM FDA clears Stelo as the first OTC CGM for kids 2+ (non‑insulin users). This pushes CGMs further into the mass‑market consumer + pediatric segment, beyond core insulin‑using patients. #DXCM #CGM #diabetes #medtech #growth https://prismmarketview.com/fda-approves-first-otc-glucose-monitor-for-kids-gets-green-light/
0 · Reply
StageAnalysis
StageAnalysis Jun. 14 at 8:51 PM
Weekend Video Part 1: US Watchlist Stocks – $CAVA, $DXCM, $HTFL (7mins) ▪️Login for full length weekend video (53mins) discussing all the important data for the Stage Analysis method (made famous in Stan Weinstein's classic book) https://www.stageanalysis.net/blog/1392110/stage-analysis-members-video-14-june-2026
0 · Reply
StageAnalysis
StageAnalysis Jun. 13 at 11:23 PM
New Blog Post: US Stocks Watchlist There are 22 stocks highlighted from the weekends US stocks watchlist scans – $CAVA, $DXCM, $HTFL https://www.stageanalysis.net/blog/1391908/us-stocks-watchlist-15-june-2026
0 · Reply
Cutlass
Cutlass Jun. 12 at 8:15 PM
$DXCM FDA clears first over-the-counter glucose monitor for children REUTERS 3:13 PM ET 6/12/2026
0 · Reply
Cutlass
Cutlass Jun. 12 at 8:14 PM
$DXCM June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has expanded the use of Dexcom's(DXCM) Stelo Glucose Biosensor System to children with diabetes, making it the first over-the-counter continuous glucose monitor for pediatric use.
0 · Reply
JInvestTrade
JInvestTrade Jun. 11 at 11:49 PM
https://www.linkedin.com/posts/eversense365-eversensecgm-diabetes-ugcPost-7470182248596635649-LTci/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_campaign=share_via $SENS $DXCM $TNDM $PODD $ABBV
0 · Reply
purdiestpam
purdiestpam Jun. 10 at 8:29 PM
$DXCM is dexcoms biggest buyer Iran? Every time we go back to combat this tanks. How is this so heavily related😂
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jun. 10 at 6:48 PM
$DXCM wtf one step forward two steps back
0 · Reply
Chrissytina
Chrissytina Jun. 10 at 4:42 PM
$DXCM 4 recent upgrades with the lowest one being $85-$95 and all of them maintain a buy ratings! So why the sudden drop? WTF
0 · Reply
Lupus_Leoque_Holdings
Lupus_Leoque_Holdings Jun. 10 at 4:26 PM
Heard a Libra FreeStyle commercial on Pandora music the other day... Sounds like $ABT and $DXCM are REALLY worried about shrinking market share. $SENS being our largest holding has us like:
1 · Reply
Johnny_Lever
Johnny_Lever Jun. 9 at 7:42 PM
$DXCM Making some moves this week.
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jun. 9 at 6:23 PM
$DXCM should be 90 by now
0 · Reply
Cutlass
Cutlass Jun. 9 at 1:27 PM
$DXCM Mizuho Maintains Outperform on DexCom, Raises Price Target to $85 BENZINGA 8:27 AM ET 6/9/2026
0 · Reply